16-16-dimethylprostaglandin-e2 has been researched along with Hepatitis--Animal* in 1 studies
1 other study(ies) available for 16-16-dimethylprostaglandin-e2 and Hepatitis--Animal
Article | Year |
---|---|
Involvement of tumor necrosis factor-alpha in the pathogenesis of activated macrophage-mediated hepatitis in mice.
The possible involvement of tumor necrosis factor-alpha in the pathogenesis of an experimentally induced hepatitis was investigated. Balb/c mice were primed with Propionibacterium acnes to induce the infiltration of mononuclear cells into the liver. Immunohistochemical study showed that most of the accumulated mononuclear cells at 7 days were Mac-2 positive, suggesting that they were activated macrophages. An injection of lipopolysaccharide resulted in massive hepatic necrosis and high mortality in the mice within 24 hours. Plasma tumor necrosis factor-alpha activity initially rose sharply and then declined over 3 hours. The increase in plasma aminotransferase activity correlated well with the elevation of plasma tumor necrosis factor-alpha activity. Pretreatment with dexamethasone or 16,16-dimethyl-prostaglandin E2 attenuated not only the elevation of plasma tumor necrosis factor-alpha activity but also the increase in plasma aminotransferase activity and improved the survival rate. Passive immunization against tumor necrosis factor-alpha showed protective effects. These findings suggest that tumor necrosis factor-alpha released from activated macrophages may play a crucial role in the pathogenesis of this murine hepatitis. Topics: 16,16-Dimethylprostaglandin E2; Alanine Transaminase; Animals; Dexamethasone; Hepatitis, Animal; Immunization, Passive; Immunohistochemistry; Macrophage Activation; Male; Mice; Mice, Inbred BALB C; Tumor Necrosis Factor-alpha | 1990 |